Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5209201
Max Phase: Preclinical
Molecular Formula: C28H31BrN4O
Molecular Weight: 519.49
Associated Items:
ID: ALA5209201
Max Phase: Preclinical
Molecular Formula: C28H31BrN4O
Molecular Weight: 519.49
Associated Items:
Canonical SMILES: CN1C=C2C[C@@H]3[C@H](C[C@@H](CNC(=O)/C=C/c4c[nH]c5ccc(Br)cc45)CN3C)C3C=CC=C1C23
Standard InChI: InChI=1S/C28H31BrN4O/c1-32-15-17(10-23-21-4-3-5-25-28(21)19(11-26(23)32)16-33(25)2)13-31-27(34)9-6-18-14-30-24-8-7-20(29)12-22(18)24/h3-9,12,14,16-17,21,23,26,28,30H,10-11,13,15H2,1-2H3,(H,31,34)/b9-6+/t17-,21?,23+,26+,28?/m0/s1
Standard InChI Key: DQEHMMIGNRXOJK-VFPSNQSSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 519.49 | Molecular Weight (Monoisotopic): 518.1681 | AlogP: 4.92 | #Rotatable Bonds: 4 |
Polar Surface Area: 51.37 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.12 | CX LogP: 3.28 | CX LogD: 0.04 |
Aromatic Rings: 2 | Heavy Atoms: 34 | QED Weighted: 0.56 | Np Likeness Score: 0.61 |
1. Johnson JW, Ellis MJ, Piquette ZA, MacNair C, Carfrae L, Bhando T, Ritchie NE, Saliba P, Brown ED, Magolan J.. (2022) Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery., 13 (2.0): [PMID:35178184] [10.1021/acsmedchemlett.1c00648] |
Source(1):